J.‐F. COLOMBEL

Statistics

Publications

Citations

363

H-Index

Active since

2006

Affiliations

Hôpital Claude Huriez(Current)

Centre Hospitalier Universitaire de Lille

Universitair Ziekenhuis Leuven

Icahn School of Medicine at Mount Sinai

John Radcliffe Hospital

J.‐F. COLOMBEL is an author at Hôpital Claude Huriez specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and inflammatory disease pharmacotherapy.

Publications per year

2006–2015

Publications

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Matthieu Allez, Séverine Vermeire, Nicolas Mozziconacci et al. · Alimentary Pharmacology & Therapeutics · 2009 · 113 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

William J. Sandborn, J.‐F. COLOMBEL, Matthew Frankel et al. · Gut · 2010 · 87 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

P. Rutgeerts, Brian G. Feagan, Colleen Marano et al. · Alimentary Pharmacology & Therapeutics · 2015 · 86 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?

J.‐F. Rahier, Yazdan Yazdanpanah, J.‐F. COLOMBEL et al. · Gut · 2009 · 42 citations

Medicine, Immunology, Infectious Diseases +17

Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions

Clotilde Duburque, J. Lelong, Răzvan Iacob et al. · Alimentary Pharmacology & Therapeutics · 2006 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 5